These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1714104)

  • 1. Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.
    Murase N; Demetris AJ; Matsuzaki T; Yagihashi A; Todo S; Fung J; Starzl TE
    Surgery; 1991 Jul; 110(1):87-98. PubMed ID: 1714104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
    Murase N; Demetris AJ; Kim DG; Todo S; Fung JJ; Starzl TE
    Surgery; 1990 Nov; 108(5):880-9. PubMed ID: 2237770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.
    Langrehr JM; Hoffman RA; Demetris AJ; Lee KK; Neuhaus P; Wren SM; Ildstad ST; Schraut WH
    Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease.
    Hoffman AL; Makowka L; Banner B; Cai X; Cramer DV; Pascualone A; Todo S; Starzl TE
    Transplantation; 1990 Mar; 49(3):483-90. PubMed ID: 1690469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts.
    Langrehr JM; Demetris AJ; Banner B; Müller AR; Thalmann U; Lee TK; Lee KK; Schraut WH
    Transpl Int; 1994; 7(2):71-8. PubMed ID: 7513999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells.
    Kimura T; Hasegawa T; Nakai H; Azuma T; Usui N; Sasaki T; Okada A
    Transplantation; 2003 May; 75(9):1469-74. PubMed ID: 12792499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small bowel rejection in isolated small bowel transplantation and in multivisceral transplantation: a comparative study in a large animal model.
    Nishida S; Komokata T; Ogata S; Ikoma A; Hamada N; Tanaka K; Yoshida H; Taira A
    In Vivo; 1998; 12(2):259-66. PubMed ID: 9627811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of FK506 and RS61443 for reversal of small-bowel rejection.
    Stangl MJ; Gräb C; Fischer T; Mebert H; Weiss M; Hammer C
    Transpl Int; 1992; 5 Suppl 1():S274-7. PubMed ID: 14621800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal glutamine utilization after small-bowel transplantation: an electrophysiologic study.
    Lee TK; Cardona MA; Kurkchubasche AG; Smith SD; Mueller AR; Lee KK; Rowe MI; Schraut WH
    J Surg Res; 1992 Jun; 52(6):605-14. PubMed ID: 1382152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The many faces of multivisceral transplantation.
    Starzl TE; Todo S; Tzakis A; Alessiani M; Casavilla A; Abu-Elmagd K; Fung JJ
    Surg Gynecol Obstet; 1991 May; 172(5):335-44. PubMed ID: 2028370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats.
    Pech T; Fujishiro J; Finger T; von Websky M; Stoffels B; Wehner S; Abu-Elmagd K; Kalff JC; Schaefer N
    Transpl Immunol; 2011 Sep; 25(2-3):112-8. PubMed ID: 21820512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive mechanism and immune tolerance of FK 506 in rat small bowel transplantation.
    Nakai T; Kawabe T; Satoh S; Kurooka K; Yasutomi M
    Transplant Proc; 1996 Apr; 28(2):1091-3. PubMed ID: 8623237
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic benefits of longer graft in rat allogenic small bowel transplantation.
    Fujishiro J; Tahara K; Inoue S; Kaneko T; Kaneko M; Hashizume K; Kobayashi E
    Transplantation; 2005 Jan; 79(2):190-5. PubMed ID: 15665767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of FK 506 on small intestine allotransplantation in the rat.
    Hoffman AL; Makowka L; Cai X; Banner B; Cramer DV; Pascualone A; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):76-7. PubMed ID: 1689907
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
    Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
    Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
    Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
    Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.